Cargando…
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
Human epidermal growth factor receptor 2 (HER2 or ErbB2) can be overexpressed, amplified and/or mutated in malignant tumors, and is a candidate for therapeutic targeting. However, molecular associations and clinical significances of these alterations were controversial in lung cancer. In this study,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287480/ https://www.ncbi.nlm.nih.gov/pubmed/28146588 http://dx.doi.org/10.1371/journal.pone.0171280 |